Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational, Multicenter Study of the Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patient Populations Diagnosed With Early-Onset Idiopathic Bilateral Cataracts

NCT02638220 is registered in ClinicalTrials.gov with Travere Therapeutics, Inc. as lead sponsor.

NCT NCT02638220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02638220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational, Multicenter Study of the Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patient Populations Diagnosed With Early-Onset Idiopathic Bilateral Cataracts
Lead sponsor
Travere Therapeutics, Inc.
Phase
Observational
Overall status
Completed
Start date
September 30, 2015
Completion date
February 19, 2021
Enrollment
442 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrotendinous xanthomatosis (ctx)